Noxopharm has appointed Dr Olivier Laczka as its new Chief Executive Officer with immediate effect, marking a leadership transition as the clinical-stage company positions itself to capitalise on emerging opportunities in its pipeline. …
Noxopharm appoints Dr Olivier Laczka as CEO to lead next phase of growth
April 15, 2026 Australian Biotech
Latest Video
New Stories
-
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News -
Why hospitals, and not medicines, dominate America’s health spending gap
April 17, 2026 - - Latest News -
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 - - Latest News -
New strategic alliance for Biointelect aims to fast track life sciences innovation
April 17, 2026 - - Latest News -
Why US health spending looks much higher than it really is
April 16, 2026 - - Latest News -
Pharmacy prescribing reform signals shift in NSW primary care with Victoria to follow
April 15, 2026 - - Latest News -
Noxopharm appoints Dr Olivier Laczka as CEO to lead next phase of growth
April 15, 2026 - - Australian Biotech